Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
61.91
-1.91 (-2.99%)
At close: Apr 1, 2025, 4:00 PM
62.34
+0.43 (0.69%)
After-hours: Apr 1, 2025, 4:11 PM EDT

Sarepta Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
6,00711,6149,02111,3757,84113,454
Upgrade
Market Cap Growth
28.75%28.75%-20.70%45.06%-41.72%39.87%
Upgrade
Enterprise Value
6,27211,8318,67710,9077,42012,422
Upgrade
Last Close Price
63.82121.5996.43129.5890.05170.49
Upgrade
PE Ratio
26.4849.37----
Upgrade
Forward PE
7.4615.47----
Upgrade
PS Ratio
3.196.117.2612.1911.1724.91
Upgrade
PB Ratio
4.057.6010.5029.558.4517.66
Upgrade
P/TBV Ratio
7.747.7410.8730.148.5817.98
Upgrade
P/FCF Ratio
----532.53
Upgrade
P/OCF Ratio
----125.19
Upgrade
EV/Sales Ratio
3.306.226.9811.6910.5723.00
Upgrade
EV/EBITDA Ratio
24.5246.25----
Upgrade
EV/EBIT Ratio
28.7654.25----
Upgrade
EV/FCF Ratio
----491.69
Upgrade
Debt / Equity Ratio
0.880.881.614.201.231.41
Upgrade
Debt / EBITDA Ratio
3.743.74----
Upgrade
Debt / FCF Ratio
-----42.47
Upgrade
Asset Turnover
0.530.530.390.300.230.23
Upgrade
Inventory Turnover
2.102.103.905.214.123.90
Upgrade
Quick Ratio
2.742.743.233.635.054.99
Upgrade
Current Ratio
4.204.203.954.135.755.97
Upgrade
Return on Equity (ROE)
19.71%19.71%-86.15%-107.16%-49.57%-70.14%
Upgrade
Return on Assets (ROA)
3.77%3.77%-5.24%-10.68%-9.04%-14.67%
Upgrade
Return on Capital (ROIC)
5.34%5.34%-7.90%-16.47%-14.21%-20.84%
Upgrade
Return on Capital Employed (ROCE)
6.70%6.70%----
Upgrade
Earnings Yield
3.74%2.02%-5.94%-6.19%-5.34%-4.12%
Upgrade
FCF Yield
-5.45%-2.95%-6.40%-3.13%-6.14%0.19%
Upgrade
Buyback Yield / Dilution
-16.75%-16.75%-5.53%-7.75%-4.24%-5.90%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q